Top Markets
#1 Islamic Coin Islamic Coin +154.35%
#2 PulseChain PulseChain +49.22%
#3 BOOK OF MEME BOOK OF MEME +27.67%
#4 Starpower Starpower +17.49%
#5 RedStone RedStone +17.36%
#6 edgeX edgeX +14.39%
#7 Lighter Lighter +12.64%
#8 Bio Protocol Bio Protocol +12.18%
#9 Not in Employment, Education, or Training Not in Employment, Education, or Training +10.93%
#10 Monad Monad +10.74%
Coin of the day
Islamic Coin Islamic Coin
Settings
Language
ENGLISH
Currency
USD
Theme
Neurizon Therapeutics Limited Neurizon Therapeutics Limited

Neurizon Therapeutics Limited

NUZ
Rank in Stocks #27535
Neurizon Therapeutics Limited, a clinical stage biotechnology company, develops... Neurizon Therapeutics Limited, a clinical stage biotechnology company, develops therapeutics for neurodegenerative diseases. The company develops drug discovery intellectual property for the treatment of neurological diseases. Its lead candidate is NUZ-001, a small molecule drug which is in Phase II clinical trials for the treatment of amyotrophic lateral sclerosis, as well as to treat other neurodegenerative diseases. The company was formerly known as PharmAust Limited and changed its name to Neurizon Therapeutics Limited in October 2024. Neurizon Therapeutics Limited was incorporated in 2000 and is based in Melbourne, Australia.
Share Price
$0.0416118
Market Cap
$32.25M
Change (1 day)
-1.67%
Change (1 year)
-59.58%
Country
AU
Trade Neurizon Therapeutics Limited (NUZ)

Category

Healthcare
Number of shares outstanding for Neurizon Therapeutics Limited (NUZ)
Number of shares outstanding as of August 2026: 0
According to Neurizon Therapeutics Limited latest financial reports and stock price the company's current number of shares outstanding is 0. At the end of August 2026 the company had 0 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for Neurizon Therapeutics Limited (NUZ) from 2026 to 2026
Shares Outstanding at the end of each year
Year Shares Outstanding Change
Not enough data for the provided dates.
Shares Outstanding for similar companies or competitors
Company Shares Outstanding Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 253.90M -
US
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 396.00M -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 62.19M -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 483.58M -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH